According to a recent LinkedIn post from ABM Respiratory Care, the company is exhibiting its BiWaze airway clearance platform at the Minnesota Society for Respiratory Care Summit in Waite Park, Minnesota. The post highlights product demonstrations of BiWaze Cough and BiWaze Clear, as well as an educational session on Oscillating Lung Expansion therapy and related clinical insights.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post suggests ABM Respiratory Care is targeting respiratory therapists and clinical decision-makers who influence equipment adoption across hospital and home-care settings. Increased professional engagement at such specialty summits could support future demand for the BiWaze portfolio, potentially strengthening the company’s positioning in the airway clearance segment.
By emphasizing features such as a dual blower system for bi-directional inhalation and exhalation control and a closed breathing circuit intended to aid mucus mobilization and aerosol deposition, the post underscores ABM’s focus on differentiated technology. If these capabilities gain clinical acceptance and are backed by emerging studies, they may support premium pricing, recurring revenue from device placements, and competitive differentiation versus established respiratory care manufacturers.
The event-focused promotion, combined with links to request demos for those unable to attend, indicates an ongoing commercial push rather than a discrete product launch. For investors, this activity may signal continued go-to-market investment and efforts to expand the installed base, which over time could translate into higher sales volumes, stronger relationships with providers, and a more defensible niche in respiratory care.